PMV Pharmaceuticals, Inc. Earnings Per Share Diluted

Quick Answer

PMV Pharmaceuticals, Inc. reported Earnings Per Share Diluted of $1.48 (loss) per share for the year ending 2025.

  • PMV Pharmaceuticals, Inc. showed a decrease of -29.8% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from PMV Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
  • XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2020 to 2025), PMV Pharmaceuticals, Inc.'s Earnings Per Share Diluted has grown by 38.3%.
  • Historical annual values: Fiscal year 2025: $1.48 (loss) per share | Fiscal year 2024: $1.14 (loss) per share | Fiscal year 2023: $1.44 (loss) per share | Fiscal year 2022: $1.61 (loss) per share | Fiscal year 2021: $1.28 (loss) per share | Fiscal year 2020: $2.40 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: